President Trump on Friday announced another deal with UK-based pharmaceutical company AstraZeneca to lower drug costs for Americans on Medicaid. The drug manufacturer will now sell prescription drugs to patients at Most Favored Nations prices through TrumpRx.gov.
The post UPDATE: President Trump Announces Major Deal with Drugmaker AstraZeneca, Including $50 BILLION Investment appeared first on The Gateway Pundit.